Immediate Impact

1 by Nobel laureates 4 from Science/Nature 61 standout
Sub-graph 1 of 24

Citing Papers

Cancer therapy with antibodies
2024 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout
3 intermediate papers

Works of Thomas Gribbin being referenced

Feasibility and results of a randomized phase Ιb study of fractionated 90Υ-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having two or more prior therapies.
2014
Genomic structure and chromosomal localization of the human deoxycytidine kinase gene.
1993

Author Peers

Author Last Decade Papers Cites
Thomas Gribbin 56 117 30 48 18 232
Wen Guan 46 178 27 11 20 262
Xiaoxiao Xu 40 168 22 8 20 288
Cinzia Bologna 98 127 10 49 17 292
Limin Huang 60 148 24 7 21 295
Elke Malenke 79 123 30 6 13 294
Si’Ana A. Coggins 41 152 26 7 14 242
Yanyun Du 55 164 14 7 16 256
Zhou Wei 29 107 38 6 19 291
Maksim Klimiankou 81 80 9 23 32 268
Nobuyoshi Hanaoka 66 101 6 11 26 271

All Works

Loading papers...

Rankless by CCL
2026